Ir-UA
Ir-UA is an usnic acid-derived iridium (III) complex that enhances PD-L1 expression and converts "cold tumors" into "hot tumors." Ir-UA stimulates PD-L1 expression by explicitly regulating the PD-L1 transcription factor[1].
Product Specifications
CAS Number
3033235-42-3
UNSPSC
12352211
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ir-ua.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C(O)=C2C(C)(C(OC2=C1C(C)=O)=CC/3=O)C(C3=C(C)\NCC4=CC=[N](C(C5=[N]6C=CC(C)=C5)=C4)[Ir+3]786(C9=CC=CC=C9C%10=[N]8C=CC=C%10)[N]%11=CC=CC=C%11C%12=CC=CC=C%127)=O)C.[F-][P+5]([F-])([F-])([F-])([F-])[F-]
Molecular Formula
C52H43F6IrN5O6P 2+
Molecular Weight
1171.11
References & Citations
[1]Deng D, et al. Iridium (III) -Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy. J Med Chem. 2024 Apr 25;67 (8) :6810-6821.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
H00009684-P01-10ug 10 µg
Recombinant Human LRRC14 Protein - (Dry Ice)
Sign In for Pricing
View Details MBS9428243-02 5x 96 Tests
Human Tryptophan 5-hydroxylase 1 ELISA Kit
Sign In for Pricing
View Details